Form D Explorer

Inspect source fieldsReport a record issue

Form D — BioGene Therapeutics Inc.

0002140719-26-000001 · filed Jul 23, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$4,550,000
Reported amount sold
$4,550,000
Minimum investment
$0
Investors
6
Sales commission
$0
Finders' fees
$0

Issuer

Name
BioGene Therapeutics Inc.
CIK
2140719
Entity
Corporation
Jurisdiction
TEXAS
Year incorporated
2024
Address
5900 BALCONES DR, STE 100
AUSTIN, TX 78731
Phone
1-512-379-7526

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗